Topic
Addiction medicine
About: Addiction medicine is a research topic. Over the lifetime, 1070 publications have been published within this topic receiving 23685 citations.
Papers published on a yearly basis
Papers
More filters
TL;DR: This is the last issue of the Drug and Alcohol Review to be published under my hand as Editor in Chief, and I have chosen to paint a broader canvas and examine how the field of addiction and addiction journals has developed over this period.
Abstract: This is the last issue of the Drug and Alcohol Review to be published under my hand as Editor in Chief, a position to which I was appointed in 1983 and which I shall demit as from January 2009 afte...
1 citations
01 Jan 2021
TL;DR: The modern era of pharmacotherapy for opioid use disorders began with the introduction of methadone maintenance in the 1960s, and since then, four medications, in different formulations, have received approval for its use by the United States Food and Drug Administration as mentioned in this paper.
Abstract: The modern era of pharmacotherapy for opioid use disorders began with the introduction of methadone maintenance in the 1960s. Since then, four medications, in different formulations, have received approval for its use by the United States’ Food and Drug Administration. Yet, practically speaking, only two medications, buprenorphine and naltrexone, are available to clinicians in addiction medicine. Why? What forces and events determined which medications are, and are not, available today? It is a story, largely untold, that continues to shape our practices and still governs our use of these medications. That story is the subject of this chapter. We hope its retelling will prompt readers to reflect on why we do what we do in using these medications, and reconsider what we can do, or not do, that may yet benefit our patients.
1 citations
TL;DR: Clinical management of sex addiction is divided into four sections: one discussing the early stages of the "addiction" process, one discussing treatment and therapy, another discussing special populati as discussed by the authors.
Abstract: Clinical Management of Sex Addiction is divided into four sections: one discussing the early stages of the “addiction” process, one discussing treatment and therapy, one discussing special populati
1 citations
TL;DR: If the desire is to ensure their EDs are safer for patients, the broader inclusion of pharmacists as a part of the ED team is a step the authors need to take.
Abstract: cient, timely and equitable patient-centred care is what we all strive to deliver, within the many challenges of the environment and system in which we work. Clinical pharmacists are an essential part of the ED multidisciplinary team and the adoption into practice of the roles and services outlined in the SHPA Standard needs to be a priority to improve the care provided to our patients. In my ED, we are fortunate to have ED pharmacists as a core part of our team. Their contributions are significant, including direct patient contact, liaising with GPs and other pharmacists, as well as contributing to the development of ED protocols, management pathways and the education of staff. If our desire is to ensure our EDs are safer for patients, the broader inclusion of pharmacists as a part of the ED team is a step we need to take.
1 citations
1 citations